Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma
Status:
Recruiting
Trial end date:
2024-08-16
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of cryoablation combined
with Sintilimab plus lenvatinib in patients with advanced intrahepatic Cholangiocarcinoma
after progression on first line systemic therapy.